Table 1.
Measurement schedule for the participants of the ENVIS-ion trial.
| Recruitment, Screening & Baseline | Annualreview (1 yr) | Annualreview (3 yr) | Annualreview (5 yr) | |
|---|---|---|---|---|
| ENVIS-ion study | ||||
| Brain MRI & RVI | X | X | ||
| Additional cognitive function testsa | X | X | ||
| ASPREE parent study | ||||
| Inclusion/exclusion criteria; informed consent | X | |||
| Cognitive function testsb | X | X | X | X |
| Demographics & physical measuresc | X | X | X | X |
| Blood pressure & cardiovascular biomarkersd | X | X | X | X |
| Health behaviors & lifestyle measurementse | X | X | X | X |
a Stoop test (Victoria version) & Color Trails test b 3 MS, Digit Symbol Modalities test, COWAT, and Hopkins Verbal hearing test c Includes first language, level of education, height, weight, abdominal circumference, family history & co-morbidity; d Includes total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, C-Reactive Protein, Hemoglobin, fasting glucose & creatinine;e Includes physical activity, smoking history & alcohol use, SF-36 & IADL